Skip to main content

Table 6 Comparison between the three studied groups according to BECLIN1

From: Serum Beclin 1 and autophagy-related protein-5 and the risk of hepatocellular carcinoma among cirrhotic hepatitis C patients

BECLIN1 (ng/ml) Cirrhotic HCC Control H p
(n = 30) (n = 30) (n = 20)
Min. – Max 1.20–12.0 3.90 – 19.80 0.70–13.60 22.344*  < 0.001*
Mean ± SD 5.62 ± 2.46 8.65 ± 3.30 4.49 ± 3.06
Median 5.25 7.90 4.70
IQR 4.15 – 6.95 6.20 – 10.40 3.10 – 6.60
Sig. bet. grps p1 < 0.001*, p2 = 0.200, p3 = 0.001*
  1. H: H for Kruskal Wallis test, Pairwise comparison bet. each 2 groups were done using Post Hoc Test (Dunn's for multiple comparisons test)
  2. p: p value for comparing between the studied groups
  3. p1: p value for comparing between Cirrhotic and HCC
  4. p2: p value for comparing between Cirrhotic and Control
  5. p3: p value for comparing between HCC and Control
  6. *: Statistically significant at p ≤ 0.05